 OSAKA, Japan DURHAM, N.C.--BUSINESS WIRE--Santen Pharmaceutical Co., Ltd. Santen and Aerie Pharmaceuticals, Inc. NASDAQ: AERI, Aerie announced that Santen and Aerie have entered into an exclusive development and commercialization agreement for Rhopressa and Rocklatan in Japan, along with rights for several other Asian countries. Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of 